Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.
暂无分享,去创建一个
V. Agnello | G. Abel | M. Elfahal | G. Knight | Q. Zhang | V Agnello | G Abel | M Elfahal | G B Knight | Q X Zhang | Qing-Xiu Zhang | Mutasim Elfahal
[1] H. Okamoto,et al. Association of circulating hepatitis G virus with lipoproteins for a lack of binding with antibodies. , 1996, Biochemical and biophysical research communications.
[2] M. Ackermann,et al. Porcine reproductive and respiratory syndrome virus enters cells through a low pH-dependent endocytic pathway. , 1996, Virus research.
[3] E. Kuechler,et al. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[4] S. Ranganathan,et al. A rapid flow cytometric assay for low-density lipoprotein receptors in human peripheral blood mononuclear cells. , 1995, The Journal of laboratory and clinical medicine.
[5] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[6] E. Rassart,et al. The epitopes of apolipoprotein A-I define distinct structural domains including a mobile middle region. , 1991, The Journal of biological chemistry.
[7] C C Howe,et al. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.
[8] P. Chen,et al. Human rheumatoid factor crossidiotypes. I. WA and BLA are heat-labile conformational antigens requiring both heavy and light chains , 1986, The Journal of experimental medicine.
[9] S. Bombardieri,et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. , 1995, QJM : monthly journal of the Association of Physicians.
[10] H. Tilg,et al. Induction of circulating IL-1 receptor antagonist by IFN treatment. , 1993, Journal of immunology.
[11] R. Thomssen,et al. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus , 1999, Journal of medical virology.
[12] Dina G. Fischer,et al. An antiviral soluble form of the LDL receptor induced by interferon. , 1993, Science.
[13] M. Yanagi,et al. Contamination of commercially available fetal bovine sera with bovine viral diarrhea virus genomes: implications for the study of hepatitis C virus in cell cultures. , 1996, The Journal of infectious diseases.
[14] R. Mahley,et al. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. , 1977, The Journal of biological chemistry.
[15] J. Kaptein,et al. Flow cytometric evaluation of LDL receptors using DiI-LDL uptake and its application to B and T lymphocytic cell lines. , 1994, Journal of immunological methods.
[16] T. Parker,et al. Visualization of hepatitis C virions and putative defective interfering particles isolated from low‐density lipoproteins , 1996, Journal of viral hepatitis.
[17] R. Donis,et al. Isolation of a mutant MDBK cell line resistant to bovine viral diarrhea virus infection due to a block in viral entry. , 1995, Virology.
[18] Y. Marcel,et al. Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. , 1990, The Journal of biological chemistry.
[19] V. Agnello,et al. A competitive reverse transcription-polymerase chain reaction assay for quantitation of GB virus C/hepatitis G virus RNA that circumvents heteroduplex artifact. , 1999, Journal of virological methods.
[20] V. Agnello,et al. Detection of widespread hepatocyte infection in chronic hepatitis C , 1998, Hepatology.
[21] V. Bonagura,et al. Human rheumatoid factor cross-idiotypes. IV. Studies on WA XId-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds , 1993, The Journal of experimental medicine.
[22] C. Packard,et al. Receptor-mediated low density lipoprotein catabolism in man. , 1979, Journal of lipid research.
[23] W. Stremmel,et al. Establishment of persistent hepatitis C virus infection and replication in vitro. , 1997, The Journal of general virology.
[24] E. J. Stott,et al. Viral contamination of bovine foetal serum and cell cultures , 1977, Nature.
[25] N. Cooper,et al. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis. , 1978, Journal of immunology.
[26] H. Varmus,et al. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor , 1993, Cell.
[27] V. Agnello,et al. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. , 1997, Arthritis and rheumatism.
[28] R. Mahley,et al. The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. , 1983, The Journal of biological chemistry.
[29] Carolyn A. Converse,et al. Lipoprotein analysis : a practical approach , 1992 .
[30] R. Chung,et al. A role for hepatitis C virus infection in type II cryoglobulinemia. , 1992, The New England journal of medicine.
[31] P. Tijssen,et al. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. , 1994, Virology.